Pulmonary Thromboembolism in Cancer Patients: Early Rule-out From the Emergency Department
Recruiting
Observational Study
Pulmonary Thromboembolisms
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 500 (estimated)
- Sponsor
- IRCCS Azienda Ospedaliero-Universitaria di Bologna · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Pulmonary thromboembolism is a frequent complication of cancer; in some cases, it is diagnosed occasionally during diagnostic examinations as part of the regular follow-up of the disease. Not all patients diagnosed with thromboembolism present symptoms; therefore, after appropriate investigations during observation in the emergency room and/or a short hospitalisation in Emergency Medicine, they co…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age ≥ 18 years
* Diagnosis of pulmonary embolism (symptomatic and/or incidental)
* Active onco-haematological disease (disease followed in oncological/haematological and/or metastatic setting)
* Informed consent to the study
Exclusion Criteria:
* Patients returning to the Em…
Contacts